Iodide

Iodide

SCHEMBL15212223

C[n+]1ccc(N2CCCC2)cc1.[I-]

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG

The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE known ✓ P22303 1/20 0.48
CHKA P35790 13/20 0.50
BCHE P06276 1/20 0.48
KDM4E B2RXH2 1/20 0.43
MEN1 O00255 1/20 0.43
NPC1 O15118 1/20 0.43
USP2 O75604 1/20 0.43
ALDH1A1 P00352 1/20 0.43
TP53 P04637 1/20 0.43
POLB P06746 1/20 0.43
GAA P10253 1/20 0.43
MAPT P10636 1/20 0.43
THRB P10828 1/20 0.43
ALOX15 P16050 1/20 0.43
HTT P42858 1/20 0.43
RECQL P46063 1/20 0.43
RAB9A P51151 1/20 0.43
KMT2A Q03164 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
HSD17B10 Q99714 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6784241 0.98 CHKA (0.52) CHKABCHEACHEKDM4EMEN1
Water SCHEMBL15212791 0.95 CHKA (0.50) CHKABCHEACHEKDM4EMEN1
SCHEMBL17327846 0.95 CHKA (0.53) CHKABCHEACHEKDM4EMEN1
Iodide SCHEMBL15212390 0.89 CHKA (0.68) CHKABCHEACHEMEN1ALDH1A1
Iodide SCHEMBL17870555 0.83 SNCA (0.53) ACHEKDM4EMEN1ALDH1A1MAPT
Iodide SCHEMBL17870554 0.83 SNCA (0.53) ACHEKDM4EMEN1ALDH1A1MAPT
SCHEMBL16183105 0.81 PTGS2 (0.53) ACHEKDM4EMEN1ALDH1A1MAPT
SCHEMBL1673290 0.78 ADRB1 (0.59) KDM4EUSP2ALDH1A1HSD17B10
Iodide SCHEMBL15212150 0.77 CHKA (0.59) CHKABCHEACHE
Iodide SCHEMBL15212212 0.75 CHKA (0.58) CHKABCHEACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9890050-B2 Molecular sieve material, its synthesis and use EXXONMOBIL CHEMICAL PATENTS INC. (US) 2018-02-13 US disclosed
EP-2817262-B1 MOLECULAR SIEVE MATERIAL, ITS SYNTHESIS AND USE EXXONMOBIL CHEMICAL PATENTS INC (US) 2017-11-15 EP disclosed
US-20160368778-A1 Molecular Sieve Material, Its Synthesis and Use EXXONMOBIL CHEMICAL PATENTS INC. 2016-12-22 US disclosed
US-9452423-B2 Molecular sieve material, its synthesis and use EXXONMOBIL CHEMICAL PATENTS INC. (US) 2016-09-27 US disclosed
US-20150025291-A1 Molecular Sieve Material, Its Synthesis and Use EXXONMOBIL CHEMICAL PATENTS INC. 2015-01-22 US disclosed
EP-2817262-A1 MOLECULAR SIEVE MATERIAL, ITS SYNTHESIS AND USE ExxonMobil Chemical Patents Inc. (US) 2014-12-31 EP disclosed
WO-2013126140-A1 MOLECULAR SIEVE MATERIAL, ITS SYNTHESIS AND USE EXXONMOBIL CHEMICAL PATENTS INC. (US) 2013-08-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150025291-A1 Molecular Sieve Material, Its Synthesis and Use RPS17, MMP17, MRPS27 ACHE 4404/4885CHKA 4726/4885BCHE 4848/4885
US-20160368778-A1 Molecular Sieve Material, Its Synthesis and Use MMP17, RPS17, CDK17 ACHE 4357/4885CHKA 4718/4885BCHE 4850/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.